INVESTOR's COMPLAINTS FOR THE PERIOD: 01-10-2017 TO 31-12-2017
Pursuant to Regulation 13 (3) of the Securities and Exchange Board of India (Listing Obligations and disclosure Requirements) Regulations, 2015, please find enclosed the details of the complaints received during the quarter ended December 31, 2017.
Drugs body to set up panel to review efficacy of FDCs
Committee to consult all stakeholders and submit report to government for action within six months Shareholding for the Period Ended December 31, 2017
FDC Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click here Closure of Trading Window
In terms of the Code of Conduct adopted by the Company pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window of the Company will remain closed for all the Directors and Designated employees from January 31, 2018 to February 09, 2018 (both days inclusive). Board Meeting To Be Held On Wednesday, February 07, 2018
This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, February 07, 2018 at Mumbai, to interalia, consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2017. Coming Up: Case on outlawed FDCs
Patient advocacy groups and the pharmaceutical industry will be watching the fixed dose combination (FDC) medicine case, scheduled to come up in the Supreme Court this fortnight. An FDC... Outcome of Board Meeting
This is to inform that the Board of Directors at its meeting held on November 10, 2017 has approved the unaudited financial results of the Company for the quarter and half year ended September 30, 2017. Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and disclosure Requirements) Regulations, 2015, please find enclosed herewith the following:... Outcome of Board Meeting
his is to inform that the Board of Directors at its meeting held on November 10, 2017 has approved the unaudited financial results of the Company for the quarter and half year ended September 30, 2017. Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and disclosure Requirements) Regulations, 2015, please find enclosed herewith the following:... Shareholding for the Period Ended September 30, 2017
FDC Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click here Compliance Certificate For The Half Year Ended On 30-09-2017
This is to certify that pursuant to Regulation 7 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, we have complied with the requirements pursuant to Regulation 7 (2) by ensuring that all the activities in relation to both, Physical and Electronic, share transfer facilities i.e. Dematerlization and Rematerlization are maintained through our Registrar and Share Transfer Agent, M/s. Sharex Dynamic (India) Pvt. Ltd., who...